Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
CAPLIN POINT LABORATORIES LTD.
Caplin Point Laboratories Ltd.
NSE: CAPLIPOINT | BSE: 524742
Mid-range Performer
2092.40
34.10
(
1.66
%)
44.10% Gain from 52W Low
143.6K
NSE+BSE Volume
High vol. this week
NSE
08 Aug, 2025 12:16 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
Margin Growth
Caplin Point's Q1 net profit rises 18.4% YoY; EBITDA margin expands 220 bps to 39.3%
See details
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(4)
About
Detailed Stock Analysis for Caplin Point Laboratories Ltd. with Real-time Stock Report
Premium Feature
Please subscribe to GuruQ or StratQ
Subscribe
Sign in